Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Celon Pharma SA (0RKX) Income Statement

1 Followers

Celon Pharma SA Income Statement

Last quarter (Q2 2026), Celon Pharma SA's total revenue was zł53.65M, a decrease of 5.21% from the same quarter last year. In Q2, Celon Pharma SA's net income was zł-30.59M. See Celon Pharma SA’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementMar 26Mar 25Mar 24Mar 23Mar 22
zł 209.80Mzł 176.62Mzł 213.92Mzł 161.91Mzł 196.09M
zł -39.48Mzł 113.45Mzł 147.10Mzł 95.45Mzł 134.37M
zł 17.28Mzł 150.26Mzł 174.34Mzł 14.12Mzł 144.82M
Depreciation and Amortizationzł 46.28Mzł 51.86Mzł 50.02Mzł 44.09Mzł 41.34M
zł -10.48Mzł 14.96Mzł 32.71Mzł 9.32Mzł 27.81M
zł -56.76Mzł -36.81Mzł -27.24Mzł -69.76Mzł -10.45M
zł -2.21Mzł -2.56Mzł 7.27Mzł 890.00Kzł -4.63M
zł -58.97Mzł -39.37Mzł -19.97Mzł -36.45Mzł -15.09M
zł -79.36Mzł -34.45Mzł -28.12Mzł -39.28Mzł -11.61M
Per Share Metrics
Basic EPSzł -1.47zł -0.66zł -0.55zł -0.77zł -0.25
Diluted EPSzł -1.47zł -0.66zł -0.55zł -0.77zł -0.25
Weighted Average Shares Outstanding53.86M52.51M51.06M51.02M46.68M
Weighted Average Shares Outstanding (Diluted)53.86M52.52M51.06M51.02M46.68M

Currency in PLN

Celon Pharma SA Earnings and Revenue History

-120M0120M240M-60 %-30 %0 %30 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin